Chemokines and Monocyte Adhesion in Atherosclerosis
Author Information
Author(s): Papadopoulou Charikleia, Corrigall Valerie, Taylor Peter R., Poston Robin N.
Primary Institution: King’s College London
Hypothesis
This study investigates the roles of chemokines IL-8, MCP-1, and GRO-α, along with their receptors, in monocyte adhesion to human atherosclerotic plaques.
Conclusion
The study found that chemokines and their receptors significantly enhance monocyte adhesion to atherosclerotic plaques, suggesting potential therapeutic targets for atherosclerosis.
Supporting Evidence
- MCP-1 blockage reduced monocyte adhesion to 34.6% of control levels.
- GRO-α blockage reduced monocyte adhesion to 35.6% of control levels.
- IL-8 blockage reduced monocyte adhesion to 37.2% of control levels.
- CCR2 blockage reduced monocyte adhesion to 48.6% of control levels.
- CXCR2 blockage reduced monocyte adhesion to 58.4% of control levels.
Takeaway
Chemokines are like sticky notes that help certain cells stick to the walls of blood vessels, which can lead to heart problems.
Methodology
The study used an adhesion assay with U937 monocytic cells and human atherosclerotic artery sections, measuring adhesion levels in the presence of specific antibodies.
Potential Biases
Potential bias may arise from the use of specific antibodies and the ex vivo nature of the adhesion assay.
Limitations
The study primarily focused on a limited number of chemokines and their receptors, and the results may not fully represent all mechanisms involved in monocyte adhesion.
Participant Demographics
Male and female patients aged between 65 and 80 with carotid stenosis greater than 70%.
Statistical Information
P-Value
<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website